口服避孕药和减小乳房整形:一个回顾性队列分析
Alyssa D Reese1, Chloe Cottone2, Katherine Foote2
1Division of Plastic and Cosmetic Surgery, Department of Surgery, Eastern Virginia Medical School, Norfolk, VA, United States.
在减小乳腺造形手术之前停止服用口服避孕药 (OCP) 并不会改善手术结果. 患者特定的因素,而不是OCP的使用,应该指导接受此程序的妇女的决定.
科学领域:
- 整形外科 整形外科 整形外科
- 妇科 妇科医生 妇科
- 血栓形成的研究研究
背景情况:
- 口服避孕药 (OCP) 被15-40岁的女性广泛使用.
- OCP与增加血栓栓塞的风险有关.
- OCPs对减少性乳房整形术结果的影响尚未得到充分了解.
研究的目的:
- 调查OCP使用与减少乳房整形手术外科结果之间的关联.
- 为了确定停止OCP是否会影响术后并发症.
主要方法:
- 追溯队列研究比较OCP用户和非用户.
- 倾向性得分与年龄,种族,分娩史和BMI相匹配.
- 在手术后六个月内分析并发症,包括血瘤,栓塞,乳腺炎和形.
主要成果:
- 在OCP使用者中,血栓塞栓或血栓形成的风险没有增加.
- 使用OCP的患者血瘤/出血的发生率较低 (1.7%对2.3%).
- 两组之间在乳腺炎,亡,脂肪亡或乳腺形方面没有显著差异.
结论:
- 在缩小乳房整形手术之前停止使用OCP并没有明显的术后益处.
- 关于OCP使用的决定应该优先考虑患者特异性因素,而不是程序性降低风险.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
05:46Introduction of Intracapsular Rotary-cut Procedures IRCP: A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
相关概念视频
Birth Control Methods
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
